Cargando…
Molecular analysis of human papillomavirus in never-smokers with non-small cell lung cancer
The causes of lung cancer in never-smokers remain unclear. The potential contribution of human papillomavirus (HPV) to the carcinogenesis of non-small cell lung cancer (NSCLC) has been reported. In 2008, a prospective registry of never-smokers with NSCLC was established at the Kinki-Chuo Chest Medic...
Autores principales: | ISA, SHUN-ICHI, KURAHARA, YU, YAMAMOTO, SATOMI, TAMIYA, AKIHIRO, OMACHI, NAOKI, ASAMI, KAZUHIRO, OKISHIO, KYOICHI, UTSUMI, TOMOKI, ITO, NORIMASA, YOON, HYUNG-EUN, MATSUMURA, AKIHIDE, ATAGI, SHINJI, KAWAGUCHI, TOMOYA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301494/ https://www.ncbi.nlm.nih.gov/pubmed/25621070 http://dx.doi.org/10.3892/ol.2014.2713 |
Ejemplares similares
-
Programmed Death-ligand 1 Expression With Clone 22C3 in Non-small Cell Lung Cancer: A Single Institution Experience
por: Takeda, Maiko, et al.
Publicado: (2019) -
A High PD-L1 Expression in Pulmonary Pleomorphic Carcinoma Correlates with Parietal-pleural Invasion and Might Predict a Poor Prognosis
por: Naito, Maiko, et al.
Publicado: (2018) -
Population pharmacokinetics of afatinib and exposure-safety relationships in Japanese patients with EGFR mutation-positive non-small cell lung cancer
por: Nakao, Keiko, et al.
Publicado: (2019) -
Efficacy of nanoparticle albumin-bound paclitaxel regimens for relapsed small cell lung cancer: A retrospective analysis
por: Naito, Yujiro, et al.
Publicado: (2017) -
Predictive factors for progression‐free survival in non‐small cell lung cancer patients receiving nivolumab based on performance status
por: Adachi, Yuichi, et al.
Publicado: (2019)